Innovent has ongoing clinical programs that could support regulatory filings in additional markets, but no specific timeline has been announced for US or European submissions
GLP-1 + GIP + Glucagon Receptor Activation All benefits of GLP-1 activation (appetite, fullness, insulin) GIP enhances insulin response and may reduce GLP-1 side effects Glucagon increases thermogenesis and energy expenditure Combined effect exceeds sum of individual pathways The idea of using glucagon for weight loss was considered counterintuitive until researchers discovered that glucagons metabolic effects depend heavily on the hormonal context
commented that: the results of in vitro measurements using pQCT and Archimedes principle, in addition to ash weight determinations, [imply] that the increases in cortical and total BMC were due to an increased growth of the bones with increased bone dimensions, whereas the volumetric BMD was unchanged
Multi-peptide formulations are often evaluated in qualified laboratory environments where researchers are studying peptide interactions, molecular signaling pathways, protein expression, extracellular matrix biology, peptide chemistry, and analytical peptide characterization
